Alpha Cognition Inc. cash flow statement
In fiscal 2025, Alpha Cognition Inc.'s operations generated −$20.4m of cash; it spent $293,489 on capital projects, leaving free cash flow of −$20.7m.
Cash flow statement
| Quarter | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | −2 | −6 | −5 | −7 | −12 | −7 |
| Depreciation and amortisation | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based pay | 1 | 1 | 1 | 1 | 1 | 1 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −2 | −6 | −5 | −7 | −12 | −7 |
| Free cash flow after stock pay | −3 | −8 | −7 | −8 | −13 | −8 |
Compare with peers
- Keros Therapeutics, Inc. cash flow
- Alector, Inc. cash flow
- Lineage Cell Therapeutics, Inc. cash flow
- Proqr Therapeutics N.V. cash flow
- Cytomx Therapeutics, Inc. cash flow
Head to head: ACOG vs KROSACOG vs ALECACOG vs LCTX
More: Biotechnology stocks compared, Health Care sector, rankings of US companies